Liver Transplantation and Hepatobiliary Medicine Unit, Royal Free Hospital, Pond Street, London NW3 2QG, UK.
Gut. 2011 Sep;60(9):1224-8. doi: 10.1136/gut.2010.235408. Epub 2011 Mar 14.
Ulcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is usually clinically mild. The aim of the study was to assess whether there is an association between severity of PSC and activity of UC, comparing the course of UC in patients with PSC not needing liver transplantation (LT) and those eventually transplanted.
Between 1990 and 2009, 96 consecutive patients with PSC/UC were seen in the authors' institution. Data were evaluated from a database regarding UC activity (median follow-up 144 months). Follow-up was censored at time of LT or last clinical review.
Patients with PSC/UC were divided into two groups: 46 did not need LT (no-LT) and 50 were transplanted (LT). There were no significant differences concerning duration of UC or PSC and extent of UC. The LT group had significantly (p=0.002) more clinically quiescent UC compared with the no-LT group. The LT group had fewer UC flare-ups (p=0.04) and required fewer steroid courses (p=0.025) with shorter duration (p=0.022) and less use of azathioprine (p=0.003). There was an increased need for surgery in the no-LT group (p=0.006). Colon carcinoma and high grade dysplasia were more frequent in the no-LT group (p=0.004). The no-LT group had increased inflammation in the colonic mucosa at histology (p=0.011), but without visual difference at colonoscopy.
Clinically progressive PSC requiring LT is associated with a milder course of UC (reduced disease activity and less use of steroids, azathioprine and surgery). This is paralleled by less histological activity and reduced incidence of dysplasia and colon carcinoma.
溃疡性结肠炎(UC)合并原发性硬化性胆管炎(PSC)通常临床症状较轻。本研究旨在评估PSC 严重程度与 UC 活动度之间是否存在关联,比较未行肝移植(LT)和最终行 LT 的 PSC 合并 UC 患者的 UC 病程。
1990 年至 2009 年,作者所在机构共收治 96 例 PSC/UC 连续患者。从数据库中评估 UC 活动度数据(中位随访 144 个月)。LT 或最后临床随访时截尾。
PSC/UC 患者分为两组:46 例未行 LT(无 LT 组)和 50 例行 LT(LT 组)。两组 UC 病程和 PSC 持续时间及 UC 范围无显著差异。与无 LT 组相比,LT 组 UC 更趋于临床缓解(p=0.002)。LT 组 UC 发作次数较少(p=0.04),皮质类固醇疗程较少(p=0.025),疗程较短(p=0.022),且更少使用硫唑嘌呤(p=0.003)。无 LT 组需要手术的患者更多(p=0.006)。无 LT 组结直肠癌和高级别异型增生更为常见(p=0.004)。无 LT 组结肠黏膜组织学炎症更明显(p=0.011),但结肠镜下无明显差异。
需要 LT 的进行性 PSC 与 UC 病情较轻相关(疾病活动度降低,皮质类固醇、硫唑嘌呤和手术应用减少)。这与组织学活性降低、异型增生和结肠癌发生率降低有关。